TABLE 2.
Model | Dose | Parameters | Results | References | Limitations |
---|---|---|---|---|---|
rat model of arsenic-induced diabetes | 300 mg/kg | reduction in oxidative stress | SIRT3 pathway activation | Javadipour et al. (2019) | SIRT3 expression elevated parallel to other antioxidant defense component |
diabetic mouse model | 250 mg/kg | improvements in lipid metabolism and a reduction in oxidative stress | Increased paraoxonase activity | Roxo et al. (2019) | Uncreated metabolic memory associated with diabetes |
Rat model | 1 mmol/L | Reduction in oxidative stress | activation of the SIRT3 and AMPK pathways | Lai et al. (2016) | the lack of beneficial effects of nitrite and metformin in the more severely affected and older rats |
Diabetic rat model | 500 mg/kg metformin and L-ergothioneine | significantly increased the expression of major antioxidant transcription factors and cytoprotective genes | Activation of Nrf2 antioxidant | Dare et al. (2021) | experimental phase, no evidence for only metformin beneficial properties, combined therapy may leads to cardiac injury |
AMPK, 5′AMP-activated protein kinase; Nrf2, Nuclear factor E2-related factor 2; SIRT3, sirtuin 3.